α-L-Fucosidase Assay Kit (CNPF Substrate Method) - NMPA Registration 京械注准20242400072
Access comprehensive regulatory information for α-L-Fucosidase Assay Kit (CNPF Substrate Method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 京械注准20242400072 and owned by Beijing Baiao Taikang Biotechnology Co., Ltd.. The device was approved on February 07, 2024.
This page provides complete registration details including registrant information, province location (Beijing), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
The product is used for in vitro quantitative detection of alpha in human serum samples; -L-fucosidase activity.
该产品用于体外定量检测人血清样本中alpha;-L-岩藻糖苷酶的活性。
试剂1:Good#39; s缓冲液100mmol/L2-氯-4-硝基苯-alpha;-L-岩藻吡喃糖苷(CNPF)65mmol/L
试剂1：Good#39;s缓冲液100mmol/L2-氯-4-硝基苯-alpha;-L-岩藻吡喃糖苷（CNPF）65mmol/L
The product is stored at 2°C~8°C in the dark, and the expiration date is 18 months.
该产品在2℃～8℃避光保存，有效期为18个月。